1814
0
13.05.2020 GILD Daily Analysis
Remdesivir the potential Covid-19 treatment drug made by Gilead Sciences (NASDAQ:GILD) licensed the drug to five generic drug manufacturers
Yazar: editor_1
Yayınlanma: 13 Mayıs 2020 15:44
Güncellenme: 8 Kasım 2024 20:07
13.05.2020 GILD Daily Analysis
Remdesivir the potential Covid-19 treatment drug made by Gilead Sciences (NASDAQ:GILD) licensed the drug to five generic drug manufacturers in India and Pakistan to speed up the supply chain development and help the anticipated demand. Cipla Ltd., Ferozsons Laboratories, Hetero Labs Ltd., Jubilant Lifesciences, and Mylan (NASDAQ:MYL) are the five companies licensed for the drug. They will be able to produce the drug without any royalty payment until another COVID-19 treatment is found or until the World Health Organization announces an end to the pandemic. Gilead Sciences Inc (GILD) is down by $2.85, or by -3.53%, at $77.95.İLGİLİ HABERLER
European stocks soared and focus shifted to German retail sales after Powell's speech!
Forex Signal For TRY/USD: Inflation Slowdown in November.
Forex Signal For GBP/USD: Bullish Trend Still Not Breaking While Recovery Continues.
Forex Signal For EUR/USD: Starry US Data Points to Higher Fed Increases.
Forex Signal For BTC/USD: Downside Continues as Bitcoin Recovery Moves Less.
En Popüler Haberler
Yorum Yap
Yorumlar
Henüz yorum yapan yok! İlk yorumu siz yapın...